Human Influenza Virus A&B Rtk Antigen Test Kit
Brand Name:KISSH
Certification:CE
Model Number:K603-1
Payment Terms:T/T
Place of Origin:CHINA
Packaging Details:1 test/kit，20 tests/kit
Contact Now
Add to Cart
Active Member
Location:
Shenzhen China
Address:
301,Building B1,Compass Life Science Industrial Park, Julongshan Road A, Pingshan District, Shenzhen,China
Supplier`s last login times:
within 1 hours
Product Details
Company Profile
Product Details
SARS-CoV-2 Human Influenza Virus A&B(Flu A&B)Antigen Test Kit ( Colloidal Gold )
Basis Information
The novel coronaviruses (SARS-CoV-2) belong to the β genus.
COVID-19 is an acute respiratory infectious disease. People are
generally susceptible. Currently, the patients infected by the
novel coronavirus are the main source of infection; asymptomatic
infected people can also be an infectious source. Based on the
current epidemiological investigation, the incubation period is 1
to 14 days, mostly 3 to 7 days. The main manifestations include
fever, fatigue and dry cough. Nasal congestion, runny nose, sore
throat, myalgia anddiarrhea are found in a few cases. Patients with
symptoms might rapidly develop into severe pneumonia, respiratory
failure, septic shock, multiple organ failure, severe acid-base
metabolism disorders, etc. which can be life-threatening. There is
an urgent need for rapid tests to manage the ongoing pandemic.
Along with the common cold influenza is one of the most common
acute respiratory infections producing symptoms such as headache
chills dry cough body aches and fever.
The influenza A virus is typically more prevalent and is associated
with the most serious influenza epidemics while influenza B
infections usually present with milder symptoms. Diagnosis is
difficult because the initial symptomscan be similar to those
caused by other infectious agents. Considering that the influenza
virus is highly contagious accurate diagnosis and prompt treatment
of patients can have a positive effect on public health. Accurate
diagnosis and the ability to distinguish between A or B antigens
can also help reduce the inappropriate use of antibiotics and gives
the physician the opportunity to prescribe an antiviral therapy.
Initiation of antiviral therapy should begin as soon as possible
after onset ideally within 48 hours of the appearance of symptoms
as treatment may reduce the duration of symptoms.
Test can provide rapid detection of influenza A and/or B viral
antigens from symptomatic patients.
Product information
| Function | SARS-CoV-2/Flu A&B Detection |
| Advantage | High specificity and high sensitivity |
| Methodology | Colloidal Gold |
| Intended Use | Qualitative detection and differentiation of nucleocapsid protein antigens from SARS-CoV-2, influenza type A and influenza type B |
| Keep temperature | 2-30℃ |
| Place of Origin | Shenzhen China |
Human Influenza Virus A&B Rtk Antigen Test Kit
Inquiry Cart
0